HCAT Health Catalyst, Inc.

Nasdaq healthcatalyst.com


$ 2.19 $ -0.07 (-3.13 %)    

Tuesday, 18-Nov-2025 15:57:20 EST
QQQ $ 598.14 $ 0.00 (0 %)
DIA $ 461.70 $ 0.00 (0 %)
SPY $ 661.82 $ 0.00 (0 %)
TLT $ 89.01 $ 0.00 (0 %)
GLD $ 377.37 $ 0.00 (0 %)
$ 2.17
$ 2.23
$ 2.21 x 2,307
$ 3.77 x 161
-- - --
$ 2.16 - $ 9.24
564,334
na
153.49M
$ 1.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 02-26-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-01-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-07-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-10-2020 09-30-2020 10-Q
22 08-12-2020 06-30-2020 10-Q
23 05-13-2020 03-31-2020 10-Q
24 02-28-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-23-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 citigroup-maintains-neutral-on-health-catalyst-lowers-price-target-to-325

Citigroup analyst Daniel Grosslight maintains Health Catalyst (NASDAQ:HCAT) with a Neutral and lowers the price target from ...

 stifel-maintains-hold-on-health-catalyst-lowers-price-target-to-375

Stifel analyst David Grossman maintains Health Catalyst (NASDAQ:HCAT) with a Hold and lowers the price target from $4.5 to $...

 wells-fargo-maintains-overweight-on-health-catalyst-lowers-price-target-to-5

Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target f...

 health-catalysts-twistle-by-health-catalyst-lumeon-by-health-catalyst-and-upfront-by-health-catalyst-achieve-hitrust-r2-certification

Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and servic...

 health-catalyst-sees-q4-sales-73500m-vs-76016m-est

Health Catalyst (NASDAQ:HCAT) sees Q4 sales of $73.500 million vs $76.016 million analyst estimate.

 health-catalyst-affirms-fy2025-sales-guidance-of-310000m-vs-312152m-est

Health Catalyst (NASDAQ:HCAT) affirms FY2025 sales outlook from $310.000 million to $310.000 million vs $312.152 million estimate.

 health-catalyst-q3-adj-eps-006-inline-sales-76323m-beat-75900m-estimate

Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is ...

 evercore-isi-group-maintains-in-line-on-health-catalyst-lowers-price-target-to-3

Evercore ISI Group analyst Elizabeth Anderson maintains Health Catalyst (NASDAQ:HCAT) with a In-Line and lowers the price ta...

 keybanc-maintains-overweight-on-health-catalyst-lowers-price-target-to-4

Keybanc analyst Scott Schoenhaus maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target from ...

 cantor-fitzgerald-reiterates-neutral-on-health-catalyst-maintains-4-price-target

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Neutral and maintains $4 price target.

 btig-reiterates-neutral-on-health-catalystto-neutral

BTIG analyst David Larsen reiterates Health Catalyst (NASDAQ:HCAT) from Neutral to Neutral.

 canaccord-genuity-maintains-buy-on-health-catalyst-lowers-price-target-to-5

Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lowers the price target from ...

 evercore-isi-group-maintains-in-line-on-health-catalyst-raises-price-target-to-4

Evercore ISI Group analyst Elizabeth Anderson maintains Health Catalyst (NASDAQ:HCAT) with a In-Line and raises the price ta...

 piper-sandler-downgrades-health-catalyst-to-neutral-lowers-price-target-to-4

Piper Sandler analyst Jessica Tassan downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to Neutral and lowers the pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION